Tag: AEGIS-II

AEGIS-II: ApoA-1 did not reduce MACE in patients with myocardial infarction but may provide benefit in patients with high LDL levels

Presented By

Prof. Michael Gibson, Harvard Medical School, MA, USA

Trial

Phase 3, AEGIS-II

Conference

ACC 2024

Type

Peer-reviewed article